Captrust Financial Advisors Bluebird Bio, Inc. Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

A detailed history of Captrust Financial Advisors transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 160,355 shares of BLUE stock, worth $65,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160,355
Previous 317,786 49.54%
Holding current value
$65,745
Previous $406,000 61.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.85 - $1.26 $133,816 - $198,363
-157,431 Reduced 49.54%
160,355 $157,000
Q1 2024

May 15, 2024
BUY
$0.91 - $1.75 $210,382 - $404,582
231,190 Added 266.98%
317,786 $406,000
Q4 2023

Feb 14, 2024
BUY
$1.32 - $4.83 $26,567 - $97,213
20,127 Added 30.28%
86,596 $119,000
Q3 2023

Nov 14, 2023
BUY
$3.02 - $4.05 $52,834 - $70,854
17,495 Added 35.72%
66,469 $202,000
Q2 2023

Aug 14, 2023
BUY
$2.79 - $5.03 $99,605 - $179,576
35,701 Added 268.97%
48,974 $161,000
Q1 2023

May 15, 2023
SELL
$3.14 - $8.22 $9,313 - $24,380
-2,966 Reduced 18.26%
13,273 $42,000
Q4 2022

Feb 15, 2023
BUY
$5.77 - $8.49 $9,001 - $13,244
1,560 Added 10.63%
16,239 $112,000
Q3 2022

Nov 16, 2022
BUY
$3.75 - $7.39 $10,125 - $19,953
2,700 Added 22.54%
14,679 $93,000
Q2 2022

Aug 16, 2022
SELL
$2.94 - $5.23 $1,643 - $2,923
-559 Reduced 4.46%
11,979 $50,000
Q1 2022

May 16, 2022
SELL
$4.07 - $10.6 $11,233 - $29,256
-2,760 Reduced 18.04%
12,538 $61,000
Q4 2021

Feb 14, 2022
SELL
$8.96 - $16.31 $26,593 - $48,408
-2,968 Reduced 16.25%
15,298 $153,000
Q3 2021

Nov 16, 2021
SELL
$11.24 - $21.0 $62,764 - $117,264
-5,584 Reduced 23.41%
18,266 $349,000
Q2 2021

Aug 16, 2021
BUY
$18.04 - $22.09 $68,281 - $83,610
3,785 Added 18.86%
23,850 $763,000
Q1 2021

May 17, 2021
BUY
$16.59 - $33.89 $124,590 - $254,513
7,510 Added 59.82%
20,065 $605,000
Q4 2020

Feb 16, 2021
SELL
$27.5 - $37.92 $60,472 - $83,386
-2,199 Reduced 14.9%
12,555 $543,000
Q3 2020

Nov 17, 2020
BUY
$34.44 - $43.75 $121,779 - $154,700
3,536 Added 31.52%
14,754 $795,000
Q2 2020

Aug 14, 2020
BUY
$27.12 - $45.97 $98,635 - $167,192
3,637 Added 47.98%
11,218 $685,000
Q1 2020

May 15, 2020
BUY
$26.16 - $63.5 $37,670 - $91,440
1,440 Added 23.45%
7,581 $322,000
Q4 2019

Feb 14, 2020
BUY
$46.96 - $61.67 $288,381 - $378,715
6,141 New
6,141 $530,000
Q3 2018

Nov 15, 2018
SELL
$88.86 - $117.49 $1,421 - $1,879
-16 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$99.64 - $127.59 $1,594 - $2,041
16 New
16 $3,000

Others Institutions Holding BLUE

# of Institutions
159
Shares Held
79.5M
Call Options Held
525K
Put Options Held
634K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $31.6M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email